SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: Lance who wrote (476)11/4/1997 10:12:00 AM
From: virgil vancleave  Read Replies (1) | Respond to of 998
 
estimates were for a much greater loss than that. could this mean good things to come. let us hope so. chart looks ok here and we could see a nice breakout soon. good luck



To: Lance who wrote (476)11/4/1997 2:28:00 PM
From: Brian Pastor  Respond to of 998
 
How do you know the FDA is meeting on a CEPH drug on November 11th? Who do you call to confirm that date???



To: Lance who wrote (476)11/4/1997 2:38:00 PM
From: Brian Pastor  Read Replies (2) | Respond to of 998
 
I spoke with CEPH Investor Relations - Approval of Myotrohin or lack thereof is expected to come from FDA BY LETTER On or Before November 11, 1997. No meeting with FDA will take place. This is simply the end of the 90 day extension the FDA announced on August 11, 1997. So it appears the money is heavily betting on approval. Calls are unusually heavy on the November 12.5 series.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News